Time to speed up scientific deliveries in fibrotic interstitial lung disease: Innovative clinical trial design to improve patient care
<p><strong>Background </p></strong>Fibrotic interstitial lung diseases (fILDs) are a heterogeneous group of lung diseases associated with significant morbidity and mortality. Despite a large increase in the number of clinical trials in the last 10 years, current regulatory-ap...
| Main Authors: | , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024
|